ArticleJournal of experimental & clinical cancer research : CR2017

CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.

Ruisong Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.